PTON vs REGN
Peloton Interactive Inc (PTON) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
Peloton Interactive Inc (PTON) is a leisure company listed on NASDAQ.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported PTON revenue for 2025-06-30 was $2.49B. Net income was -$118.9M. Revenue was down 7.8% from 2024-06-30 to 2025-06-30. PTON currently screens at market cap $2.39B and trailing P/E 92.2.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
PTON currently screens at market cap $2.39B and trailing P/E 92.2. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the PTON and REGN stock pages for the full models.
Not investment advice.